EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 31 (Novembre 2015) Hors série n°3 Med Sci (Paris), 31 (2015) 20-27 References
Free Access
Issue
Med Sci (Paris)
Volume 31, Novembre 2015
Les Cahiers de Myologie
Page(s) 20 - 27
Section Mise au point
DOI https://doi.org/10.1051/medsci/201531s306
Published online 06 November 2015
  1. Amouri R, Driss A, Murayama K, et al. Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy. Neuromuscul Disord 2005 ; 15 : 361–363. [CrossRef] [PubMed] [Google Scholar]
  2. Argov Z. GNE myopathy: a personal trip from bedside observation to therapeutic trials. Acta Myol 2014 ; 33 : 107–110. [PubMed] [Google Scholar]
  3. Béhin A, Dubourg O, Laforêt P, et al. Distal myopathy due to mutations of GNE gene: clinical spectrum and diagnosis. Rev Neurol (Paris) 2008 ; 164 : 434–443. [CrossRef] [PubMed] [Google Scholar]
  4. Chamova T, Guergueltcheva V, Gospodinova M, et al. GNE myopathy in Roma patients homozygous for the p. I618T founder mutation. Neuromuscul Disord 2015 ; 25 : 713–718. [CrossRef] [PubMed] [Google Scholar]
  5. Chaouch A, Brennan KM, Hudson J, et al. Two recurrent mutations are associated with GNE myopathy in the North of Britain. J Neurol Neurosurg Psychiatry 2014 ; 85 : 1359–1365. [CrossRef] [PubMed] [Google Scholar]
  6. Eisenberg I, Avidan N, Potikha T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001 ; 29 : 83–87. [CrossRef] [PubMed] [Google Scholar]
  7. Haghighi A, Nafissi S, Qurashi A, et al. Genetics of GNE myopathy in the non-Jewish Persian population. Eur J Hum Genet 2015 May 13. doi: 10.1038/ejhg.2015.78 [Google Scholar]
  8. Huizing M, Carrillo-Carrasco N, Malicdan MC, et al. GNE myopathy: new name and new mutation nomenclature. Neuromuscul Disord 2014 ; 24 : 387–389. [CrossRef] [PubMed] [Google Scholar]
  9. Kayashima T, Matsuo H, Satoh A, et al. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet 2002 ; 47 : 77–79. [CrossRef] [PubMed] [Google Scholar]
  10. Khademian H, Mehravar E, Urtizberea J, et al. Prevalence of GNE p. M712T and hereditary inclusion body myopathy (HIBM) in Sangesar population of Northern Iran. Clin Genet 2013 ; 84 : 589–592. [CrossRef] [PubMed] [Google Scholar]
  11. Krause S, Hinderlich S, Amsili S, et al. Localization of UDP-GlcNAc 2-epimerase/ManAckinase (GNE) in the Golgi complex and the nucleus of mammalian cells. Exp Cell Res 2005 ; 304 : 365–379. [CrossRef] [PubMed] [Google Scholar]
  12. Kurochkina N, Yardeni T, Huizing M. Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria. Glycobiology 2010 ; 20 : 322–337. [CrossRef] [PubMed] [Google Scholar]
  13. Malicdan MC, Noguchi S, Nonaka I, et al. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 2007 ; 16 : 2669–2682. [CrossRef] [PubMed] [Google Scholar]
  14. Malicdan MC, Noguchi S, Nishino I. A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review. Ther Adv Neurol Disord 2010 ; 3 : 127–135. [CrossRef] [PubMed] [Google Scholar]
  15. Mori-Yoshimura M, Oya Y, Hayashi YK, et al. Respiratory dysfunction in patients severely affected by GNE myopathy (distal myopathy with rimmed vacuoles). Neuromuscul Disord 2013 ; 23 : 84–88. [CrossRef] [PubMed] [Google Scholar]
  16. Mitrani-Rosenbaum S, Yakovlev L, Becker Cohen M, et al. Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery. Neuromuscul Disord 2012 ; 22 : 1015–1024. [CrossRef] [PubMed] [Google Scholar]
  17. Malicdan MC, Noguchi S, Hayashi YK, et al. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009 ; 15 : 690–695. [CrossRef] [PubMed] [Google Scholar]
  18. Nalini A, Gayathri N, Nishino I, et al. GNE myopathy in India. Neurol India 2013 ; 61 : 371–374. [CrossRef] [PubMed] [Google Scholar]
  19. Nishino I, Carrillo-Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatry 2015 ; 86 : 385–392. [CrossRef] [PubMed] [Google Scholar]
  20. Nemunaitis G, Jay CM, Maples PB, et al. Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. Hum Gene Ther 2011 ; 22 : 1331–1341. [CrossRef] [PubMed] [Google Scholar]
  21. Park YE, Kim HS, Choi ES, et al. Limb-girdle phenotype is frequent in patients with myopathy associated with GNE mutations. J Neurol Sci 2012 ; 321 : 77–81. [CrossRef] [PubMed] [Google Scholar]
  22. Reinke SO, Lehmer G, Hinderlich S, et al. Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis. Biol Chem 2009 ; 390 : 591–599. [CrossRef] [PubMed] [Google Scholar]
  23. Sim JE, Park HJ, Shin HY, et al. Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy. Yonsei Med J 2013 ; 54 : 578–582. [CrossRef] [PubMed] [Google Scholar]
  24. Sparks S, Rakocevic G, Joe G, et al. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol 2007 ; 7 : 3. [PubMed] [Google Scholar]
  25. Tasca G, Ricci E, Monforte M, et al. Muscle imaging findings in GNE myopathy. J Neurol 2012 ; 259 : 1358–1365. [CrossRef] [PubMed] [Google Scholar]
  26. Tong Y, Tempel W, Nedyalkova L, et al. Crystal structure of the N-acetylmannosamine kinase domain of GNE. PLoS One 2009 ; 4 : e7165. [CrossRef] [PubMed] [Google Scholar]
  27. Yardeni T, Choekyi T, Jacobs K, et al. Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase. Biochemistry 2011 ; 50 : 8914–8925. [CrossRef] [PubMed] [Google Scholar]
  28. Yonekawa T, Malicdan MC, Cho A, et al. Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice. Brain 2014 ; 137 : 2670–2679. [CrossRef] [PubMed] [Google Scholar]
  29. Zhao J, Wang Z, Hong D, et al. Mutational spectrum and clinical features in 35 unrelated mainland Chinese patients with GNE myopathy. J Neurol Sci 2015 ; 354 : 21–26. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.